Speaker Profile
Ph.D., CEO, Unravel Biosciences
Biography
Richard Novak, Ph.D. is a Termeer Fellow, bioengineer and entrepreneur dedicated to solving unanswerable questions through technology innovation. Prior to Unravel Bio, he was a Lead Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he managed fast-paced programs in drug discovery, advanced disease models, human Organ Chips, and integrated automation and sensor systems. He has nearly 20 years of experience in technology and therapeutics development. He is a founder and president of the nonprofit Future Scientist and a founder and director of the sample collection automation company Rhinostics Inc.
Talk
Personalized medicine AI powered by patient RNA
Unravel empowers individual patients around the globe in their therapeutic odyssey to generate personalized medicine insights using noninvasive transcriptome collection powering causal network biology AI drug screens. With dozens of N=1 clinical successes and multiple clinical trials, we are unlocking true personalized care for the most complex disorders.
AI for Clinical Decision Support Systems Showcase:
Unravel Biosciences, Inc.
Unravel catalyzes the discovery of effective treatments for rare and complex disease patients by building Living Molecular Twins™ to enable personalized medicine. Our AI discovers shared mechanisms across many disorders that are rapidly tested in real patients using repurposed drugs, defragmenting rare disorders and improving patient outcomes today, with validation in >25 N=1 studies and two clinical trials.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
